vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and ROGERS CORP (ROG). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $200.5M, roughly 1.3× ROGERS CORP). ROGERS CORP runs the higher net margin — 2.2% vs -14.3%, a 16.6% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs 4.7%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $1.1M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -3.3%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
EHAB vs ROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $200.5M |
| Net Profit | $-38.7M | $4.5M |
| Gross Margin | — | 32.2% |
| Operating Margin | -12.3% | — |
| Net Margin | -14.3% | 2.2% |
| Revenue YoY | 4.7% | 5.2% |
| Net Profit YoY | 15.9% | 421.4% |
| EPS (diluted) | $-0.76 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $270.4M | $201.5M | ||
| Q3 25 | $263.6M | $216.0M | ||
| Q2 25 | $266.1M | $202.8M | ||
| Q1 25 | $259.9M | $190.5M | ||
| Q4 24 | $258.2M | $192.2M | ||
| Q3 24 | $253.6M | $210.3M | ||
| Q2 24 | $260.6M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-38.7M | $4.6M | ||
| Q3 25 | $11.1M | $8.6M | ||
| Q2 25 | $5.2M | $-73.6M | ||
| Q1 25 | $17.8M | $-1.4M | ||
| Q4 24 | $-46.0M | $-500.0K | ||
| Q3 24 | $-110.2M | $10.7M | ||
| Q2 24 | $-200.0K | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 3.5% | ||
| Q3 25 | 6.4% | 7.3% | ||
| Q2 25 | 6.3% | -33.3% | ||
| Q1 25 | 6.1% | -0.2% | ||
| Q4 24 | -16.0% | -6.6% | ||
| Q3 24 | -38.6% | 6.9% | ||
| Q2 24 | 4.3% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -14.3% | 2.3% | ||
| Q3 25 | 4.2% | 4.0% | ||
| Q2 25 | 2.0% | -36.3% | ||
| Q1 25 | 6.8% | -0.7% | ||
| Q4 24 | -17.8% | -0.3% | ||
| Q3 24 | -43.5% | 5.1% | ||
| Q2 24 | -0.1% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.76 | $0.20 | ||
| Q3 25 | $0.22 | $0.48 | ||
| Q2 25 | $0.10 | $-4.00 | ||
| Q1 25 | $0.35 | $-0.08 | ||
| Q4 24 | $-0.92 | $-0.04 | ||
| Q3 24 | $-2.20 | $0.58 | ||
| Q2 24 | $0.00 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $195.8M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $1.2B |
| Total Assets | $1.2B | $1.4B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $43.6M | $197.0M | ||
| Q3 25 | $56.9M | $167.8M | ||
| Q2 25 | $37.1M | $157.2M | ||
| Q1 25 | $39.5M | $175.6M | ||
| Q4 24 | $28.4M | $159.8M | ||
| Q3 24 | $45.7M | $146.4M | ||
| Q2 24 | $28.5M | $119.9M |
| Q1 26 | — | — | ||
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $534.0M | $1.2B | ||
| Q3 25 | $566.8M | $1.2B | ||
| Q2 25 | $552.4M | $1.2B | ||
| Q1 25 | $543.2M | $1.3B | ||
| Q4 24 | $523.5M | $1.3B | ||
| Q3 24 | $566.1M | $1.3B | ||
| Q2 24 | $674.3M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.4B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $5.8M |
| Free Cash FlowOCF − Capex | $3.3M | $1.1M |
| FCF MarginFCF / Revenue | 1.2% | 0.5% |
| Capex IntensityCapex / Revenue | 0.4% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $4.4M | $46.9M | ||
| Q3 25 | $37.8M | $28.9M | ||
| Q2 25 | $10.6M | $13.7M | ||
| Q1 25 | $17.9M | $11.7M | ||
| Q4 24 | $-4.1M | $33.7M | ||
| Q3 24 | $28.4M | $42.4M | ||
| Q2 24 | $9.6M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $3.3M | $42.2M | ||
| Q3 25 | $36.2M | $21.2M | ||
| Q2 25 | $8.7M | $5.6M | ||
| Q1 25 | $17.6M | $2.1M | ||
| Q4 24 | $-4.7M | $18.3M | ||
| Q3 24 | $27.7M | $25.2M | ||
| Q2 24 | $8.9M | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 1.2% | 20.9% | ||
| Q3 25 | 13.7% | 9.8% | ||
| Q2 25 | 3.3% | 2.8% | ||
| Q1 25 | 6.8% | 1.1% | ||
| Q4 24 | -1.8% | 9.5% | ||
| Q3 24 | 10.9% | 12.0% | ||
| Q2 24 | 3.4% | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.4% | 2.3% | ||
| Q3 25 | 0.6% | 3.6% | ||
| Q2 25 | 0.7% | 4.0% | ||
| Q1 25 | 0.1% | 5.0% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 0.3% | 8.2% | ||
| Q2 24 | 0.3% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | 3.41× | 3.36× | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
ROG
Segment breakdown not available.
